ArriVent BioPharma, Inc. Common Stock (AVBP) News

Latest headlines that mention AVBP, newest first · each headline opens the original publisher

AVBP quote

Last price: $15.36
Day change: -26.86%
Next earnings: 2026-11-09

Quote & chart Expected move Insider trading IV rank history

AVBP headlines

last 30 days

Investing.com 1d ago

ArriVent reports phase 1 data for cancer drug ARR-217

General T3AVBP

Investing.com 3d ago

ArriVent to present phase 1 data for ARR-217 at ESMO

General T3AVBP

Seeking Alpha News 20d ago

ArriVent BioPharma: Phase 3 Failure Resets The Investment Case (Rating Downgrade)

General T2AVBP

Seeking Alpha 20d ago

ArriVent plunges as lead asset fails in late-stage cancer trial

General T2AVBP

Reuters 20d ago

ArriVent's cancer pill fails to 'meaningfully' delay disease progression, shares dive

General T1AVBP

AVBP news alerts

Get an alert by email or push when a new headline mentions AVBP.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.